Assembly Members Krell and Aguiar-Curry's Access to Safe Abortion Care Act reaffirms California's legal framework for medication abortion while establishing new liability protections for healthcare providers and others involved in abortion care. The legislation explicitly states that activities related to abortion medications, including shipping, receiving, and administering mifepristone and misoprostol, remain lawful within California's borders.
The bill creates retroactive protections dating to January 1, 2020, shielding manufacturers, distributors, healthcare providers, pharmacists, and individuals from civil or criminal liability when handling abortion medications in accordance with state law and accepted medical standards. These provisions apply to both in-state activities and interstate transport of medications used for legal abortions in California.
According to the bill's findings, medication abortion now accounts for over 60 percent of U.S. abortions, with data showing a 0.4-percent rate of major complications. The legislation notes that California's public university health centers currently provide medication abortion services under existing state requirements. A severability clause ensures that if any portion of the law faces successful legal challenge, the remaining provisions stay in effect.
![]() Ash KalraD Assembly Member | Committee Member | Not Contacted | |
![]() Cecilia Aguiar-CurryD Assembly Member | Bill Author | Not Contacted | |
![]() Rebecca Bauer-KahanD Assembly Member | Committee Member | Not Contacted | |
![]() Akilah Weber PiersonD Senator | Bill Author | Not Contacted | |
![]() Isaac BryanD Assembly Member | Committee Member | Not Contacted |
Email the authors or create an email template to send to all relevant legislators.
Assembly Members Krell and Aguiar-Curry's Access to Safe Abortion Care Act reaffirms California's legal framework for medication abortion while establishing new liability protections for healthcare providers and others involved in abortion care. The legislation explicitly states that activities related to abortion medications, including shipping, receiving, and administering mifepristone and misoprostol, remain lawful within California's borders.
The bill creates retroactive protections dating to January 1, 2020, shielding manufacturers, distributors, healthcare providers, pharmacists, and individuals from civil or criminal liability when handling abortion medications in accordance with state law and accepted medical standards. These provisions apply to both in-state activities and interstate transport of medications used for legal abortions in California.
According to the bill's findings, medication abortion now accounts for over 60 percent of U.S. abortions, with data showing a 0.4-percent rate of major complications. The legislation notes that California's public university health centers currently provide medication abortion services under existing state requirements. A severability clause ensures that if any portion of the law faces successful legal challenge, the remaining provisions stay in effect.
Ayes | Noes | NVR | Total | Result |
---|---|---|---|---|
12 | 0 | 3 | 15 | PASS |
![]() Ash KalraD Assembly Member | Committee Member | Not Contacted | |
![]() Cecilia Aguiar-CurryD Assembly Member | Bill Author | Not Contacted | |
![]() Rebecca Bauer-KahanD Assembly Member | Committee Member | Not Contacted | |
![]() Akilah Weber PiersonD Senator | Bill Author | Not Contacted | |
![]() Isaac BryanD Assembly Member | Committee Member | Not Contacted |